Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

The series finale of It: Welcome to Derry has aired, concluding the terrifying first season. But what’s next for Pennywise the Clown and the Derry residents? HBO Max’s prequel, based on Stephen King’s ...

The Republican Party of India (Athawale) chief and Union Minister Ramdas Athawale on Tuesday said his party was excluded from the seat-sharing talks between the BJP and the Eknath Shinde-led Shiv Sena ...

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Erika Rasure is globally-recognized as a leading consumer economics ...

At HIMSS26, leaders from HL7 Da Vinci Project and Aetna will show how C-suite leaders – and all patients – can benefit from the interoperability spec, which is enabling process automation for more ...

In seconds, this artificial intelligence technology can produce new content responding to prompts Elysse Bell is a finance and business writer for Investopedia. She writes about small business, ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...